These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 28847342)

  • 1. Availability of dopamine transporters and auditory P300 abnormalities in adults with attention-deficit hyperactivity disorder: preliminary results.
    Chu CL; Lee IH; Chi MH; Chen KC; Chen PS; Yao WJ; Chiu NT; Yang YK
    CNS Spectr; 2018 Aug; 23(4):264-270. PubMed ID: 28847342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylphenidate DAT binding in adolescents with Attention-Deficit/ Hyperactivity Disorder comorbid with Substance Use Disorder--a single photon emission computed tomography with [Tc(99m)]TRODAT-1 study.
    Szobot CM; Shih MC; Schaefer T; Júnior N; Hoexter MQ; Fu YK; Pechansky F; Bressan RA; Rohde LA
    Neuroimage; 2008 Apr; 40(3):1195-201. PubMed ID: 18282769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic imaging study with [Tc-
    Akay AP; Kaya GÇ; Kose S; Yazıcıoğlu ÇE; Erkuran HÖ; Güney SA; Oğuz K; Keskin D; Baykara B; Emiroğlu Nİ; Eren MŞ; Kızıldağ S; Ertay T; Özsoylu D; Miral S; Durak H; Gönül AS; Rohde LA
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Aug; 86():294-300. PubMed ID: 29684537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pilot study on the association between the blood oxygen level-dependent signal in the reward system and dopamine transporter availability in adults with attention deficit hyperactivity disorder.
    Lin SH; Chi MH; Lee IH; Chen KC; Tai YC; Yao WJ; Chiu NT; Yang DY; Lin CY; Chen PS; Yang YK
    CNS Spectr; 2021 Jun; 26(3):299-306. PubMed ID: 32308185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Availability of Striatal Dopamine Transporter in Healthy Individuals With and Without a Family History of ADHD.
    Tai YC; Chi MH; Chu CL; Chiu NT; Yao WJ; Chen PS; Yang YK
    J Atten Disord; 2019 May; 23(7):665-670. PubMed ID: 27401239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attention deficit hyperactivity disorder: binding of [99mTc]TRODAT-1 to the dopamine transporter before and after methylphenidate treatment.
    Dresel S; Krause J; Krause KH; LaFougere C; Brinkbäumer K; Kung HF; Hahn K; Tatsch K
    Eur J Nucl Med; 2000 Oct; 27(10):1518-24. PubMed ID: 11083541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attention deficit/hyperactivity disorder: is there a correlation between dopamine transporter density and cerebral blood flow?
    da Silva N; Szobot CM; Anselmi CE; Jackowski AP; Chi SM; Hoexter MQ; Anselmi OE; Pechansky F; Bressan RA; Rohde LA
    Clin Nucl Med; 2011 Aug; 36(8):656-60. PubMed ID: 21716015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low dopamine transporter occupancy by methylphenidate as a possible reason for reduced treatment effectiveness in ADHD patients with cocaine dependence.
    Crunelle CL; van den Brink W; Veltman DJ; van Emmerik-van Oortmerssen K; Dom G; Schoevers RA; Booij J
    Eur Neuropsychopharmacol; 2013 Dec; 23(12):1714-23. PubMed ID: 23731497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SPECT and PET of the dopamine transporter in attention-deficit/hyperactivity disorder.
    Krause J
    Expert Rev Neurother; 2008 Apr; 8(4):611-25. PubMed ID: 18416663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of 99mTc-TRODAT-1 SPECT to predict clinical response to methylphenidate treatment in adults with attention deficit hyperactivity disorder.
    la Fougère C; Krause J; Krause KH; Josef Gildehaus F; Hacker M; Koch W; Hahn K; Tatsch K; Dresel S
    Nucl Med Commun; 2006 Sep; 27(9):733-7. PubMed ID: 16894328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine transporter density in the basal ganglia assessed with [123I]IPT SPET in children with attention deficit hyperactivity disorder.
    Cheon KA; Ryu YH; Kim YK; Namkoong K; Kim CH; Lee JD
    Eur J Nucl Med Mol Imaging; 2003 Feb; 30(2):306-11. PubMed ID: 12552351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine transporter imaging in adult patients with attention-deficit/hyperactivity disorder.
    Hesse S; Ballaschke O; Barthel H; Sabri O
    Psychiatry Res; 2009 Feb; 171(2):120-8. PubMed ID: 19176281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of striatal dopamine transporter availability on the response to methylphenidate in adult patients with ADHD.
    Krause J; la Fougere C; Krause KH; Ackenheil M; Dresel SH
    Eur Arch Psychiatry Clin Neurosci; 2005 Dec; 255(6):428-31. PubMed ID: 16091862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Striatal dopamine transporter availability and DAT-1 gene in adults with ADHD: no higher DAT availability in patients with homozygosity for the 10-repeat allele.
    Krause J; Dresel SH; Krause KH; La Fougère C; Zill P; Ackenheil M
    World J Biol Psychiatry; 2006; 7(3):152-7. PubMed ID: 16861140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased striatal dopamine transporter in adult patients with attention deficit hyperactivity disorder: effects of methylphenidate as measured by single photon emission computed tomography.
    Krause KH; Dresel SH; Krause J; Kung HF; Tatsch K
    Neurosci Lett; 2000 May; 285(2):107-10. PubMed ID: 10793238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced midbrain dopamine transporter binding in male adolescents with attention-deficit/hyperactivity disorder: association between striatal dopamine markers and motor hyperactivity.
    Jucaite A; Fernell E; Halldin C; Forssberg H; Farde L
    Biol Psychiatry; 2005 Feb; 57(3):229-38. PubMed ID: 15691523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Searching for a neurobiological basis for self-medication theory in ADHD comorbid with substance use disorders: an in vivo study of dopamine transporters using (99m)Tc-TRODAT-1 SPECT.
    Silva N; Szobot CM; Shih MC; Hoexter MQ; Anselmi CE; Pechansky F; Bressan RA; Rohde LA
    Clin Nucl Med; 2014 Feb; 39(2):e129-34. PubMed ID: 23856832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cognitive evoked potentials and executive functions in children with attention deficit hyperactivity disorder].
    Roca P; Mulas F; Presentación-Herrero MJ; Ortiz-Sánchez P; Idiazábal-Alecha MA; Miranda-Casas A
    Rev Neurol; 2012 Feb; 54 Suppl 1():S95-103. PubMed ID: 22374778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The dopamine transporter and neuroimaging in attention deficit hyperactivity disorder.
    Krause KH; Dresel SH; Krause J; la Fougere C; Ackenheil M
    Neurosci Biobehav Rev; 2003 Nov; 27(7):605-13. PubMed ID: 14624805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular imaging genetics of methylphenidate response in ADHD and substance use comorbidity.
    Szobot CM; Roman T; Hutz MH; Genro JP; Shih MC; Hoexter MQ; Júnior N; Pechansky F; Bressan RA; Rohde LA
    Synapse; 2011 Feb; 65(2):154-9. PubMed ID: 20593420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.